Vaccine Against Cervical Cancer

Understanding the risks of HPV and the importance of its prevention is crucial for protecting against HPV-related cancers, such as cervical, throat, and anal cancers.

Serum Institute of India aims to significantly boost supply of its human papillomavirus (HPV) vaccine as it gears up to provide its shots to the government at cheaper rates for an immunisation campaign this year against the cancer-causing virus.

The Centre on Saturday said it is yet to take a decision on the roll-out of human papillomavirus (HPV) vaccination against cervical cancer in the country.

The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per vial of two doses, official sources said on Thursday.

A day after the first indigenously developed Human Papillomavirus vaccine against cervical cancer was launched, Serum Institute of India CEO Adar Poonawalla on Wednesday said the vaccine will be available in small quantity this year.

India would be in a position to roll out the indigenously developed Human Papillomavirus Vaccine (HPV) against cervical cancer for girls in the age group of 9-14 under the National Immunisation Programme by mid-2023, NTAGI chairperson Dr NK Arora sai

Cancer: In this article, we discuss various other cancers that are extremely common.

Cervical Cancer Vaccine: Here is everything you need to know about Cervical Cancer and its risk and causes.

Cervical Cancer: According to DBT, the indigenous vaccination will prove to be inexpensive and accessible.

There are more than 100 varieties of HPV, 40 of which are passed through sexual contact and can affect the genitals, mouth or throat.

A vaccine that protects against four strains of the human papillomavirus, which can lead to cervical cancer, does not increase the risk of blood clots in women, researchers said Tuesday.

Girls are more likely to be vaccinated against HPV virus that causes cervical cancer when their mothers are prevention-minded.

A vaccine against a cervical cancer causing virus can protect young women from infection, a success researchers hope will eventually allow them to prevent many cases of cervical cancer.

Understanding the risks of HPV and the importance of its prevention is crucial for protecting against HPV-related cancers, such as cervical, throat, and anal cancers.

Serum Institute of India aims to significantly boost supply of its human papillomavirus (HPV) vaccine as it gears up to provide its shots to the government at cheaper rates for an immunisation campaign this year against the cancer-causing virus.

The Centre on Saturday said it is yet to take a decision on the roll-out of human papillomavirus (HPV) vaccination against cervical cancer in the country.

The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per vial of two doses, official sources said on Thursday.

A day after the first indigenously developed Human Papillomavirus vaccine against cervical cancer was launched, Serum Institute of India CEO Adar Poonawalla on Wednesday said the vaccine will be available in small quantity this year.

India would be in a position to roll out the indigenously developed Human Papillomavirus Vaccine (HPV) against cervical cancer for girls in the age group of 9-14 under the National Immunisation Programme by mid-2023, NTAGI chairperson Dr NK Arora sai

Cancer: In this article, we discuss various other cancers that are extremely common.

Cervical Cancer Vaccine: Here is everything you need to know about Cervical Cancer and its risk and causes.

Cervical Cancer: According to DBT, the indigenous vaccination will prove to be inexpensive and accessible.

There are more than 100 varieties of HPV, 40 of which are passed through sexual contact and can affect the genitals, mouth or throat.

A vaccine that protects against four strains of the human papillomavirus, which can lead to cervical cancer, does not increase the risk of blood clots in women, researchers said Tuesday.

Girls are more likely to be vaccinated against HPV virus that causes cervical cancer when their mothers are prevention-minded.

A vaccine against a cervical cancer causing virus can protect young women from infection, a success researchers hope will eventually allow them to prevent many cases of cervical cancer.